ArticleBMC cancer2025

The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.

Sedat Yıldırım et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.